BioCentury
ARTICLE | Company News

Abgenix and SmithKline in XenoMouse deal

May 19, 2000 7:00 AM UTC

SBH will use ABGX's XenoMouse technology to generate human monoclonal antibodies to an undisclosed target. ABGX will receive a research license payment and could receive additional fees, milestones, a...